Averion expands European operations

28 February 2007

Boston, USA. Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology, has opened four European-based offices. Averion has added many professionals, including clinicians with extensive experience conducting oncology clinical trials, to support expanded European operations, including staffing the new facilities.

“Expanding geographically is key to our growth strategy as it supports our ability to provide services to international clients and to capitalize on the rapid growth that characterizes the CRO industry,” said Philip Lavin, PhD, Averion Chief Executive Officer. “We are exceptionally pleased to recruit top quality CRO professionals with established credentials in conducting clinical trials, especially in oncology. We view oncology as a particularly attractive segment for Averion in which we have proven expertise in conducting these highly complex and often lengthy trials.”

John Shillingford, PhD, President Averion Europe GmbH, stated, “We expect this expansion will open new opportunities for Averion as it allows us to gain access in Central and Eastern Europe to large populations of patients. We have already identified clinical sites within Europe with competent, well-trained staffs to run quality trials at competitive prices.”

The new Averion offices include:

  • Averion Europe GmbH, located near Frankfurt, Germany, will provide financial, administrative and operational support for Averion’s European operations.
  • Averion Ltd., located in the United Kingdom, will oversee operations for Averion’s clinical trials in northwestern Europe and coordinate activities with Averion’s UK-based clients.
  • Averion Clinical Research GmbH, located in Austria, will handle responsibilities for Averion’s Central and Eastern European operations.
  • Averion Sp. z.o.o., located in Poland, will provide operational support and co-ordination of studies in Poland and the Baltic States.

To top

To top